1. Home
  2. FMS vs BSAC Comparison

FMS vs BSAC Comparison

Compare FMS & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMS
  • BSAC
  • Stock Information
  • Founded
  • FMS 1996
  • BSAC 1977
  • Country
  • FMS Germany
  • BSAC Chile
  • Employees
  • FMS N/A
  • BSAC N/A
  • Industry
  • FMS Misc Health and Biotechnology Services
  • BSAC Commercial Banks
  • Sector
  • FMS Health Care
  • BSAC Finance
  • Exchange
  • FMS Nasdaq
  • BSAC Nasdaq
  • Market Cap
  • FMS 15.0B
  • BSAC 12.4B
  • IPO Year
  • FMS 1996
  • BSAC 1994
  • Fundamental
  • Price
  • FMS $26.76
  • BSAC $26.50
  • Analyst Decision
  • FMS Sell
  • BSAC Hold
  • Analyst Count
  • FMS 2
  • BSAC 2
  • Target Price
  • FMS $30.00
  • BSAC $22.50
  • AVG Volume (30 Days)
  • FMS 358.2K
  • BSAC 294.5K
  • Earning Date
  • FMS 11-04-2025
  • BSAC 10-29-2025
  • Dividend Yield
  • FMS 2.13%
  • BSAC 3.75%
  • EPS Growth
  • FMS 23.39
  • BSAC 88.01
  • EPS
  • FMS 2.62
  • BSAC 0.01
  • Revenue
  • FMS $22,922,038,756.00
  • BSAC $2,504,429,686.00
  • Revenue This Year
  • FMS $2.01
  • BSAC $41.14
  • Revenue Next Year
  • FMS $3.11
  • BSAC $5.30
  • P/E Ratio
  • FMS $20.14
  • BSAC $10.86
  • Revenue Growth
  • FMS 0.53
  • BSAC 38.82
  • 52 Week Low
  • FMS $18.94
  • BSAC $18.19
  • 52 Week High
  • FMS $30.46
  • BSAC $26.83
  • Technical
  • Relative Strength Index (RSI)
  • FMS 64.67
  • BSAC 61.79
  • Support Level
  • FMS $25.05
  • BSAC $25.87
  • Resistance Level
  • FMS $26.00
  • BSAC $26.68
  • Average True Range (ATR)
  • FMS 0.33
  • BSAC 0.43
  • MACD
  • FMS 0.16
  • BSAC -0.04
  • Stochastic Oscillator
  • FMS 95.99
  • BSAC 74.62

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.

Share on Social Networks: